I-MAB (IMAB)
1.76
-0.01
(-0.56%)
USD |
NASDAQ |
May 17, 16:00
1.76
0.00 (0.00%)
After-Hours: 20:00
I-MAB Total Assets (Quarterly): 368.62M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 368.62M |
June 30, 2023 | 484.12M |
June 30, 2023 | 484.12M |
December 31, 2022 | 590.45M |
June 30, 2022 | 744.81M |
June 30, 2022 | 744.81M |
December 31, 2021 | 878.74M |
June 30, 2021 | 950.96M |
June 30, 2021 | 950.96M |
Date | Value |
---|---|
December 31, 2020 | 969.46M |
September 30, 2020 | 629.62M |
June 30, 2020 | 288.91M |
June 30, 2020 | 288.91M |
December 31, 2019 | 248.34M |
September 30, 2019 | 258.23M |
June 30, 2019 | 283.92M |
June 30, 2019 | 283.92M |
December 31, 2018 | 345.39M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
248.34M
Minimum
Dec 2019
969.46M
Maximum
Dec 2020
555.82M
Average
484.12M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
Summit Therapeutics Inc | 176.78M |
Verastem Inc | 123.54M |
CEL-SCI Corp | 30.05M |
AIM ImmunoTech Inc | 19.38M |
IGC Pharma Inc | 11.26M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 126.23M |
Shareholders Equity (Quarterly) | 242.38M |
Debt to Equity Ratio | 0.0517 |
Current Ratio | 5.674 |
Net Debt Paydown Yield | -2.73% |